Genetically engineered bacterium comprising energy-generating fermentation pathway
US-9738875-B2 · Aug 22, 2017 · US
US10316337B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10316337-B2 |
| Application number | US-201815922451-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 15, 2018 |
| Priority date | Oct 13, 2015 |
| Publication date | Jun 11, 2019 |
| Grant date | Jun 11, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a genetically engineered bacterium having an enzyme that converts 3-hydroxyisovaleryl-CoA to 3-hydroxyisovalerate and an enzyme that converts 3-hydroxyisovalerate to isobutylene. Typically, the bacterium is capable of producing isobutylene from a gaseous substrate containing CO, CO2, and/or H2, such as syngas or an industrial waste gas.
Opening claim text (preview).
The invention claimed is: 1. A genetically engineered C1-fixing bacterium comprising: (a) an enzyme that converts 3-hydroxyisovaleryl-CoA to 3-hydroxyisovalerate and (b) an enzyme that converts 3-hydroxyisovalerate to isobutylene, wherein at least one of the enzymes is exogenous to the bacterium. 2. The bacterium of claim 1 , wherein the enzyme that converts 3-hydroxyisovaleryl-CoA to 3-hydroxyisovalerate is thioesterase (EC 3.1.2.20), phosphate butyryltransferase (EC 2.3.1.19) and butyrate kinase (EC 2.7.2.7), or CoA-transferase (EC 2.8.3.9). 3. The bacterium of claim 1 , wherein the enzyme that converts 3-hydroxyisovalerate to isobutylene is hydroxyisovalerate phosphorylase/decarboxylase or mevalonate diphosphate decarboxylase (EC 4.1.1.33). 4. The bacterium of claim 1 , wherein the bacterium further comprises one or more enzymes selected from the group consisting of citramalate synthase (EC 2.3.1.182), 3-isopropylmalate dehydratase (EC 4.2.1.35), 3-isopropylmalate dehydrogenase (EC 1.1.1.85), acetolactate synthase (EC 2.2.1.6), ketol-acid reductoisomerase (EC 1.1.1.86), dihydroxyacid dehydratase (EC 4.2.1.9), ketoisovalerate oxidoreductase (EC 1.2.7.7), 2-methylbutanoyl-CoA dehydrogenase (EC 1.3.99.12), crotonase/3-hydroxybutyryl-CoA dehydratase (EC 4.2.1.55), crotonyl-CoA carboxylase-reductase (EC 1.3.1.86), crotonyl-CoA reductase (EC 1.3.1.44), 3-hydroxypropionyl-CoA dehydratase (EC 4.2.1.116), enoyl-CoA hydratase (4.2.1.17), thiolase (EC 2.3.1.9), thioesterase (EC 3.1.2.20), phosphate butyryltransferase (EC 2.3.1.19), butyrate kinase (EC 2.7.2.7), or CoA-transferase (EC 2.8.3.9), acetoacetate decarboxylase (EC 4.1.1.4), alpha-ketoisovalerate decarboxylase (EC 4.1.1.74), 3-hydroxyisovaleryl-CoA synthase, hydroxymethylglutaryl-CoA synthase (EC 2.3.3.10), 3-hydroxybutyryl-CoA dehydratase (EC 4.2.1.55), enoyl-CoA hydratase (EC 4.2.1.17), methylcrotonyl-CoA decarboxylase, and methylcrotonoyl-CoA carboxylase (EC 6.4.1.4). 5. The bacterium of claim 1 , wherein the bacterium is an anaerobe, an acetogen, an ethanologen, a carboxydotroph, or a methanotroph. 6. The bacterium of claim 1 , wherein the bacterium is derived from a parental bacterium selected from the group consisting of Acetobacterium woodii, Alkalibaculum bacchii, Blautia product, Butyribacterium methylotrophicum, Clostridium aceticum, Clostridium autoethanogenum, Clostridium carboxidivorans, Clostridium coskatii, Clostridium drakei, Clostridium formicoaceticum, Clostridium ljungdahlii, Clostridium magnum, Clostridium ragsdalei, Clostridium scatologenes, Eubacterium limosum, Moorella thermautotrophica, Moorella thermoacetica, Oxobacter pfennigii, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides , and Thermoanaerobacter kiuvi. 7. A method of producing isobutylene comprising culturing the bacterium of claim 1 in the presence of a substrate, whereby the bacterium produces isobutylene. 8. The method of claim 7 , wherein the substrate is a gaseous substrate comprising one or more of CO, CO 2 , CH 4 , and H 2 . 9. The method of claim 7 , wherein the substrate comprises syngas or industrial waste gas. 10. The method of claim 7 , wherein the bacterium is an anaerobe, an acetogen, an ethanologen, a carboxydotroph, or a methanotroph. 11. The method of claim 7 , wherein the bacterium is derived from a parental bacterium selected from the group consisting of Acetobacterium woodii, Alkalibaculum bacchii, Blautia product, Butyribacterium methylotrophicum, Clostridium aceticum, Clostridium autoethanogenum, Clostridium carboxidivorans, Clostridium coskatii, Clostridium drakei, Clostridium formicoaceticum, Clostridium ljungdahlii, Clostridium magnum, Clostridium ragsdalei, Clostridium scatologenes, Eubacterium limosum, Moorella thermautotrophica, Moorella thermoacetica, Oxobacter pfennigii, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides , and Thermoanaerobacter kiuvi.
Alcohol dehydrogenase (NADP+) (1.1.1.2), i.e. aldehyde reductase · CPC title
polyhydric · CPC title
Butyrate kinase (2.7.2.7) · CPC title
Unsaturated compounds, i.e. alkenes, alkynes or allenes · CPC title
acyclic · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.